Tweet Stopping use of low-efficacy disease modifying treatments has been a recent finding in the NHS-england. Don’t believe me well look forward to posts over the coming week. However England is not unique and here Brazil can be seen to be getting the risks of not treating effectively and is curtailing use of platform medications Marques AC, Siqueira MM, Pereira GR, Paiva LEB, Lin V, Correa LH, Souza DGB, Junior EA, Dutra LA. Real-world impact o…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.